Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Save the date for the Scandion Oncology Capital Markets Day on September 8, 2021

Scandion Oncology A/S invites investors, analysts, and media to a virtual Capital Markets Day on September 8, 2021.During the day, Scandion Oncology’s executive management will provide a corporate strategy update, a deep dive into the clinical strategy and the business opportunities to pursue our goal of becoming The Cancer Drug Resistance Company. Specific details will be provided in August, but please save the date or register now at https://www.lyyti.fi/reg/Capital_Markets_Day_Scandion_Oncology_7500 The presentation will be held in English.   For further information regarding

Indian traditional garment kurti now available with Polygiene ViralOff technology

Igyne fashion, Indian producer of kurtis, western and semi western tops, as well as other typical Indian traditional garments, is launching their first kurtis with Polygiene ViralOff[TM] antimicrobial technology starting from summer season 2021. The products are distributed via web stores, general and own retail as well as wholesale covering all of India. Production will continue comings seasons, and volumes are planned to increase. “We have chosen Polygiene ViralOff* technology to add value to our different products. For us the sustainable approach of Polygiene plays a key role, as

DrugLog® ready for launch in the US

Pharmacolog has registered DrugLog® with the US Food and Drug Administration (FDA) and can thereby sell and deliver systems to the US market.DrugLog® is used to verify the identity and concentration of injectable drugs prior to administration for increased patient safety and has been sold in Europe since 2017. The system is classified as a Class 1 Medical Device and has undergone special tests required for registration with the US Food and Drug Administration (FDA) in the North American market. With the registration with the FDA, the product is now approved for sale in the U.S. as well.

Interim report second quarter and first half of 2021

Second quarter 2021 · Order intake rose by 30% to SEK 6,006 million (4,604). For comparable units, it was an increase of 26%. · Net sales increased by 20% to SEK 5,552 million (4,614). For comparable units, it was an increase of 16%. · EBITA increased by 40% to SEK 843 million (602), corresponding to an EBITA margin of 15.2% (13.0%). · Profit for the quarter increased by 52% to SEK 562 million (370), and earnings per share amounted to SEK 1.54 (1.02). · Cash flow from operating activities amounted to SEK 792 million (806). 1 January – 30 June 2021 · Order intake

Quickbit acquires Balder Solutions AS

Quickbit has acquired 100 percent of the shares in the Norwegian company Balder Solutions AS ("Balder"). Through the acquisition, Quickbit will receive the necessary registrations required for a future launch of the Quickbit App and Quickbit Card in Norway, which is the next step in Quickbit's expansion phase. The purchase price amounts to NOK 2.5 million and is financed in its entirety with cash.“As we have communicated earlier, we intend to launch the Quickbit App and Quickbit Card in Norway after the launch in Sweden. Norway is a market with great potential for us. With the acquisition

Safeture appoints Nicola Dolovski as Commercial Director

Safeture is creating a new commercial team. Based on a holistic approach, the company will more efficiently and purposefully handle both direct and indirect commercial opportunities in the future. In this venture, Nicola Dolovski has been appointed Commercial Director. He most recently worked at Parkster and starts on August 16.A clearer focus on safety and changing behavior in working life, both due to the pandemic and digitalization, leads to an increased demand for technical solutions that ensure employees' safety no matter where they are. To develop the commercial opportunities in more

ABS Releases Industry-Leading Guidance on Autonomous and Remote-Control Technologies

New Guide Sets Out Goal-Based Framework Implementing Autonomous and Remote-Control Functions(HOUSTON) A new ABS Guide for Autonomous and Remote-Control Functions sets out a goal-based framework for the implementation of these technologies on vessels and offshore units. and introduces two new notations. The Guide introduces the ABS Remote-Control and Autonomous notations. Development of the guidance was informed by experiences on remote-control and autonomous operations tug projects in Europe, Asia and the Americas. “ABS is proud to partner with innovative companies developing some of

Wärtsilä to deliver 100MW of energy storage for Pivot Power projects in the West Midlands, England to support renewable energy integration

Wärtsilä Corporation, Press release, 19 July 2021 at 10:00 E. Europe Standard TimeThe technology group Wärtsilä will supply 100MW / 200MWh of energy storage systems to Pivot Power, part of EDF Renewables, for its next two projects in the West Midlands, England, to support the roll-out of Pivot Power’s innovative Energy Superhub model. Wärtsilä will install batteries at two sites in the city of Coventry and the borough of Sandwell, on the outskirts of Birmingham. The order was booked by Wärtsilä in Q2 2021. Construction is due to commence at Sandwell in Q4 2021 and at Coventry in Q1 2022.

EQT Exeter Europe Logistics Value Fund IV closes at EUR 2.1 billion hard cap – fortifies commitment to logistics value-add investments across Europe

· EQT Exeter Europe Logistics Value Fund IV closes at EUR 2.1 billion hard cap following strong support from existing and new international blue-chip investors · EQT Exeter Europe Logistics Value Fund IV will pursue a value-add strategy to acquire, develop, redevelop, lease, operate, and sell supply chain and e-commerce focused big box warehouse, last mile and light industrial properties serving major markets throughout Europe · The Fund is the first vehicle to close after the combination of EQT’s real estate business and Exeter Property Group, which was completed in April 2021

Aker Solutions Awarded Major Offshore Wind Contract

July 19, 2021 – Aker Solutions, as part of a consortium, has signed a major[1] EPCI contract with an undisclosed customer to provide the HVDC (high-voltage, direct current) transmission system for a large offshore wind project. More details about the project is expected to be announced by the customer and its partners during the third quarter of 2021.For Aker Solutions, the scope will involve engineering, procurement, construction and installation (EPCI) of an offshore HVDC converter platform. This platform will consist of a steel jacket substructure and a topside platform deck housing the

Vitrolife’s share buyback program completed

During the period July 15, 2021 until July 16, 2021, Vitrolife AB (publ) has repurchased a total of 52,568 shares as part of the buyback program introduced by the Board of Directors to secure the obligations of Vitrolife (including social security contributions) relating to the long-term incentive program LTIP2021. As a result, the buyback program, which Vitrolife announced on July 14, 2021, is hereby completed since the maximum amount of shares (52,568) has been repurchased. The buyback program was carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and

Dentalum strengthens the Board of Directors with Mikael Lönn as new board member

At an extraordinary general meeting, Dentalum Operations AB (publ) elected Mikael Lönn as a new board member.Mikael Lönn is a medical doctor with vast experience as a business-leader and entrepreneur, mainly within the healthcare sector. In the late 1980s, Mikael founded and managed M&M Medical, a hospital group that operated Sabbatsberg and Täby hospital in Stockholm, which was later acquired by an international company. Since then, Mikael has been an active investor and a successful entrepreneur in various industries and has held board assignments at the Swedish dental service

Veoneer partners with Baraja to deliver Spectrum-Scan LiDAR for next generation autonomous vehicles

Stockholm, Sweden, July 19, 2021: The automotive technology company Veoneer, Inc. (NYSE: VNE and SSE: VNE SDB) has signed an agreement with pioneering LiDAR company Baraja to industrialize their Spectrum-Scan™ LiDAR technology for the next market wave of L2+ through L4 autonomous vehicle applications.Under the non-exclusive agreement, Veoneer will develop, market and integrate a scalable Spectrum-Scan™ platform from Baraja to serve the automotive market. Veoneer chose to partner with Baraja after extensive testing, as Baraja offers robust technology and a roadmap that lends itself to be

2cureX receives important ISO 13485:2016 certification

2cureX has been certified for ISO 13485:2016 compliance - an important milestone in the company’s effort to bring 3D-microtumors to routine clinical practice, both from a regulatory and from a commercial perspective.In line with our strategy of becoming a full-fledged In Vitro Diagnostics (IVD) company 2cureX is happy to announce that we have been certified for ISO 13485:2016 compliance. Certification was issued by Bureau Veritas Certification Denmark A/S, a certification company accredited by DANAK. ISO 13485:2016 is the latest version of the standard for design, production,

Ideagen Boosts Offering with Two More Strategic Acquisitions

Leading provider of software solutions to companies operating in highly regulated industries, Ideagen PLC, has today announced it has made a further two acquisitions to increase its product offering.Ideagen’s strategy has been to grow geographically and by sector expertise and these two acquisitions are very much in line with that strategy, as they significantly add to Ideagen’s product offering and capabilities. The first acquisition, which was completed on Jul 9, is OpsBase, a UK-based health and safety compliance platform. The OpsBase platform will be a significant ad-on to Ideagen’s

Scientific Article Covering Immune Modulating Interstitial Laser Thermotherapy by CLS’ Co-founder Professor Karl-Göran Tranberg Published in the Journal “Frontiers in Oncology”

Lund, Sweden, 19 July, 2021 - Clinical Laserthermia Systems AB  (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced that a review article titled “Local Destruction of Tumors and Systemic Immune Effects”  has been published in the Journal “Frontiers in Oncology” by the company’s co-founder and Senior Clinical Advisor, Professor Karl-Göran Tranberg. Article Overview Current

Imfinzi approved in China for extensive-stage SCLC

19 July 2021 07:00 BST Imfinzi approved in China for the treatmentof extensive-stage small cell lung cancer Only PD-1/PD-L1 immunotherapy to demonstrate both a significant survival benefit and improved response rate in combination with a choice of chemotherapies AstraZeneca’s Imfinzi (durvalumab) has been approved in China for the 1st-line treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC), in combination with standard of care platinum chemotherapy (etoposide plus a choice of either carboplatin or cisplatin). The approval by China’s National

Peab rebuilds prison in Härnosand

Peab has been commissioned to rebuild and renovate the former prison in Härnösand. The customer is Intea Fastigheter and the contract is worth SEK 157 million.The Swedish Prison and Probation Service plans to reopen the prison in Härnösand. Intea Fastigheter owns the building and has awarded Peab the contract to refit the premises to meet current security class 2 standards and prepare space for the national transportation unit (NTE). The project includes rebuilding and renovating the facility - parts of which date back to the 1800s - to suit the incoming operations as well as maintenance

CELLINK launches the S.NEST, a high-throughput microbioreactor with real-time monitoring to ensure maximum cell growth and streamlined workflows

CYTENA Bioprocess Solutions, a CELLINK company, has launched the S.NEST™, a state-of-the art microbioreactor that maximizes cell growth while monitoring and analyzing cell conditions from start to finish. Well-known for combining innovative bioscience technologies with best-in-class software development, CYTENA Bioprocess Solutions has developed their new microbioreactor to disrupt the field of cell line development (CLD). Microbioreactors have been instrumental in a string of research breakthroughs in CLD for a range of downstream applications, but with the addition of real-time

GomSpace (provider of nanosatellites) announces its quarterly results for the second quarter 2021

Stockholm, July 19, 2021. GomSpace Group AB (the “Company”) announces its interim report for the second quarter of 2021. The report is available on the Company’s homepage (www.gomspace.com). The following is taken from the quarterly report: Second quarter summary 1 April – 30 June 2021 (2020) · Order intake increased to T.SEK 199,459 (42,342) · Net revenues increased to T.SEK 47,535 (42,729) · Gross margin increased to 14% (11%) · Operating profit (loss) improved to a negative T.SEK 12,331 (a negative 14,859) · Earnings per share were a negative SEK 0.22 (a negative 0.

Quarterly Report Q2 2021

Significant sales growth and margin recoverySecond quarter · Net sales increased by 19% to SEK 23,648 M (19,953), with strong organic growth of 23% (–18) and acquired net growth of 5% (3). Currency effects amounted to –9% (0) · Very strong organic sales growth was reported by EMEIA, Americas, Entrance Systems and Global Technologies. The organic sales growth forAsia Pacific was stable · Four acquisitions with combined annual sales of about SEK 400 M were signed · Operating income (EBIT)[ ]increased by 71% and amounted to SEK 3,589 M (2,097), corresponding to an operating

Glycorex Transplantation AB (GTAB B): Universal Whole Blood: Presentation of results at two U.S. blood conferences

As previously announced, a leading center in the U.S. has tested our UBP-product for the manufacturing of universal whole blood. We can now announce that the results will be presented as poster presentations at the Society for the Advancement of Blood Management (SABM) and the AABB. In connection with these, abstracts will also be published in two different medical journals: "Anesthesia and Analgesia" and "Transfusion".Massive bleeding is one of the leading causes of death in severe trauma. Evidence is growing suggesting that transfusion of whole blood is most appropriate in these cases,

Elgood Development Well 48/22c-7 Flow Test Results

19 July 2021 IOG plc Successful Elgood Development Well 48/22c-7 Flow Test Results IOG plc (“IOG”, or “the Company”), (AIM: IOG.L), the UK gas company targeting growth and high returns via an infrastructure-led hub strategy, is pleased to provide an update on the Elgood well 48/22c-7, our first Phase 1 development well. The well was drilled horizontally through the reservoir section to a Total Depth of 15,472ft Measured Depth (MD), intersecting 1,080 ft of high-quality Permian Leman Sandstone reservoir along hole between 14,290 ft MD and 15,370 ft MD, with a net:gross ratio of

There are no items matching the current filter
There are no more items matching the current filter
Back to top